Skip to main content

HHS Overrules FDA on Plan B

Despite scientific evidence that Plan B emergency contraception is safe for women of all ages, the department of Health and Human Services declined to approve it for over-the-counter use.

Written byTia Ghose
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

FLICKR, VIXYVIEW

After the department of Health and Human Services (HHS) overruled the Food and Drug Administration (FDA) on Wednesday regarding the approval of emergency contraceptive Plan B, many are wondering whether politics, not science, guided the decision. The department ruled to keep existing restrictions on Plan B, which currently cannot be sold without a prescription to those younger than 17, despite the FDA’s conclusion that the drug was safe and effective for fertile women of all ages and should be available over-the-counter.

As a rationale for keeping the restrictions in place, HHS head Kathleen Sebelius said that about 10 percent of women as young as 11 are physically capable of getting pregnant but may lack the cognitive and behavioral development to use Plan B properly.

But ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
From Pilot to Practice: Advancing Regulatory Reliance

From Pilot to Precedent: A Year of Regulatory Innovation through PRISM and What it Means for Cloud Adoption in Regulatory Submissions

DNAnexus
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Improving Western Blot Analysis of Biofluid Samples

Improving Western Blot Analysis of Biofluid Samples

Bio-Rad
Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter

Products

Sino Biological Logo

Sino Biological Advances AI-Designed Molecule Validation with 4RISE™

Illustrated floating metabolites and molecules

Metabolon Verus™ Kit: Metabolomics Profiling Kit

Metabolon
Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics